X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (919) 919
Book Chapter (30) 30
Book / eBook (13) 13
Magazine Article (4) 4
Conference Proceeding (3) 3
Patent (3) 3
Web Resource (2) 2
Book Review (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (515) 515
female (263) 263
male (261) 261
middle aged (234) 234
aged (220) 220
pulmonary embolism (211) 211
risk factors (194) 194
peripheral vascular disease (172) 172
cardiac & cardiovascular systems (164) 164
adult (158) 158
venous thromboembolism (157) 157
hematology (131) 131
anticoagulants - therapeutic use (126) 126
prevention (118) 118
medicine, general & internal (116) 116
thromboembolism (116) 116
thrombosis (112) 112
abridged index medicus (107) 107
treatment outcome (95) 95
risk (88) 88
deep-vein thrombosis (86) 86
venous thrombosis (83) 83
anticoagulants (81) 81
diagnosis (78) 78
aged, 80 and over (75) 75
pulmonary embolism - diagnosis (75) 75
care and treatment (74) 74
pulmonary embolism - drug therapy (74) 74
mortality (73) 73
prophylaxis (72) 72
drug therapy (70) 70
acute disease (69) 69
prospective studies (68) 68
thrombolytic therapy (68) 68
warfarin (62) 62
management (61) 61
anticoagulants - administration & dosage (60) 60
pulmonary embolism - diagnostic imaging (59) 59
pulmonary-embolism (59) 59
risk assessment (59) 59
anticoagulants - adverse effects (58) 58
hemorrhage - chemically induced (56) 56
time factors (56) 56
deep vein thrombosis (55) 55
heparin (52) 52
embolism (50) 50
hospitalization (50) 50
respiratory system (50) 50
venous thrombosis - prevention & control (50) 50
cardiology (48) 48
therapy (48) 48
health aspects (47) 47
anticoagulation (45) 45
pulmonary embolism - prevention & control (45) 45
internal medicine (44) 44
pulmonary embolism - epidemiology (44) 44
follow-up studies (43) 43
stroke (43) 43
thrombolysis (43) 43
echocardiography (42) 42
venous thromboembolism - prevention & control (40) 40
united states (39) 39
health risk assessment (38) 38
heparin - therapeutic use (38) 38
ultrasonography (38) 38
fibrinolytic agents - therapeutic use (37) 37
pulmonary embolism - etiology (37) 37
pulmonary embolism - therapy (36) 36
registries (36) 36
research (36) 36
incidence (35) 35
prognosis (35) 35
atrial fibrillation (34) 34
hemorrhage (34) 34
venous thromboembolism - drug therapy (34) 34
cardiovascular (33) 33
molecular-weight heparin (33) 33
pulmonary embolism - mortality (33) 33
pulmonary embolism - complications (32) 32
surgery (32) 32
venous thrombosis - drug therapy (32) 32
risk-factors (31) 31
warfarin - therapeutic use (31) 31
cancer (29) 29
cardiovascular disease (29) 29
deep venous thrombosis (29) 29
recurrence (29) 29
trial (29) 29
analysis (28) 28
medicine & public health (28) 28
outcomes (28) 28
patients (28) 28
retrospective studies (28) 28
usage (28) 28
venous thromboembolism - epidemiology (28) 28
venous thrombosis - epidemiology (28) 28
double-blind method (27) 27
angiography (26) 26
bleeding (26) 26
critical care medicine (26) 26
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (9) 9
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Gerstein Science - Circulation Desk (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1993, Fundamental and clinical cardiology, Volume 12., xviii, 607
Book
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 4, pp. 351 - 360
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 8, pp. 752 - 762
Patients with coronary artery disease were randomly assigned to either methotrexate (15 to 20 mg weekly) or placebo. At a median of 2.3 years, there was no... 
C-REACTIVE PROTEIN | RHEUMATOID-ARTHRITIS | TRIAL | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | REDUCTION | CANTOS | INFLAMMATION | DISEASE | RISK | CANCER | Confidence Intervals | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Interleukin-1beta - blood | Interleukin-6 - blood | Statistics, Nonparametric | Cardiovascular Diseases - mortality | Female | C-Reactive Protein - analysis | Diabetes Mellitus, Type 2 - complications | Immunosuppressive Agents - administration & dosage | Stroke - prevention & control | Double-Blind Method | Proportional Hazards Models | Coronary Artery Disease - drug therapy | Metabolic Syndrome - complications | Methotrexate - adverse effects | Myocardial Infarction - complications | Stroke - etiology | Myocardial Infarction - drug therapy | Coronary Artery Disease - complications | Immunosuppressive Agents - adverse effects | Methotrexate - administration & dosage | Transaminases - blood | Aged | Atherosclerosis - prevention & control | Myocardial infarction | C-reactive protein | Heart attacks | Liver | Hematocrit | Cardiovascular disease | Angina | Metabolic syndrome | Folic acid | Interleukin 6 | Proteins | Atherosclerosis | Methotrexate | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cerebral infarction | Cytokines | Diabetes mellitus | Inflammation | IL-1β | Patients | Investigations | Disease prevention | Rheumatoid arthritis | Arteriosclerosis | Monoclonal antibodies | Diabetes | Health risk assessment | Metabolic disorders | Pharmaceuticals
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 6, pp. 534 - 544
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 24, pp. 2283 - 2293
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 23, pp. 2240 - 2252
Journal Article